The Novel ATR Inhibitor BAY 1895344 Is Efficacious as Monotherapy and Combined With DNA Damage-Inducing or Repair-Compromising Therapies in Preclinical Cancer Models

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-19-0019
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

GEMMs as Preclinical Models for Testing Pancreatic Cancer Therapies

DMM Disease Models and Mechanisms
ImmunologyMolecular BiologyBiochemistryMicrobiology NeuroscienceMedicineGenetics
2015English

DNA Damage, Repair and Misrepair in Cancer and in Cancer Therapy

2011English

PARP Inhibitor Veliparib and HDAC Inhibitor SAHA Synergistically Co-Target the UHRF1/BRCA1 DNA Damage Repair Complex in Prostate Cancer Cells

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2018English

Significant Therapeutic Efficacy With Combined Radioimmunotherapy and Cetuximab in Preclinical Models of Colorectal Cancer

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2015English

Sirtuin 1-Mediated Deacetylation of XPA DNA Repair Protein Enhances Its Interaction With ATR Protein and Promotes cAMP-induced DNA Repair of UV Damage

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2018English

The ATR Barrier to Replication-Born DNA Damage

DNA Repair
BiochemistryCell BiologyMolecular Biology
2010English

The Use of Novel PET Tracers to Image Breast Cancer Biologic Processes Such as Proliferation, DNA Damage and Repair, and Angiogenesis

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2016English

Lamins Reach Out to Novel Functions in DNA Damage Repair

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2011English

DNA Damage and Repair in Endometrial Cancer in Correlation With the hOGG1 and RAD51 Genes Polymorphism

Molecular Biology Reports
MedicineGeneticsMolecular Biology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy